discrimin
steril
inflamm
infect
especi
case
asept
loosen
versu
actual
prosthet
joint
infect
challeng
signific
treatment
implic
goal
evalu
novel
human
monoclon
antibodi
mab
probe
direct
gramposit
bacteri
surfac
molecul
lipoteicho
acid
lta
specif
affin
assess
vitro
radiolabel
antilta
mab
evalu
effect
diagnost
imag
tool
detect
infect
via
immunopet
imag
vivo
mous
model
prosthet
joint
infect
pji
vitro
ex
vivo
bind
antilta
mab
pathogen
bacteria
measur
octet
elisa
flow
cytometri
vivo
pji
mous
model
assess
use
tradit
imag
modal
includ
positron
emiss
tomographi
pet
f
fdg
f
naf
well
xray
comput
tomographi
ct
evalu
antibodi
specif
lta
zr
antilta
mab
exhibit
specif
bind
vitro
ltaexpress
bacteria
result
imag
show
model
could
reliabl
simul
infect
surgic
site
bioluminesc
imag
convent
pet
tracer
imag
bone
morpholog
chang
ct
one
day
follow
inject
radiolabel
antilta
isotyp
control
antibodi
antilta
antibodi
demonstr
significantli
greater
p
uptak
aureusinfect
prosthesi
site
either
antibodi
steril
prosthesi
site
control
nonspecif
antibodi
infect
prosthesi
site
taken
togeth
radiolabel
antilta
mab
zr
may
serv
valuabl
diagnost
molecular
imag
probe
help
distinguish
steril
inflamm
infect
set
pji
futur
studi
need
determin
whether
find
translat
human
pji
bone
research
http
doi
total
joint
arthroplasti
common
orthoped
surgic
procedur
signific
benefit
also
challeng
complic
especi
relat
infect
prosthet
joint
infect
pji
infect
involv
implant
adjac
bone
joint
tissu
affect
primari
arthroplasti
result
estim
case
cost
exceed
billion
current
standard
care
therapi
chronic
pji
hip
knee
involv
complet
remov
infect
tissu
implant
eventu
hardwar
replac
prolong
antibiot
therapi
success
treatment
occur
case
failur
often
requir
treatment
surgeri
even
amput
total
number
total
hip
total
knee
arthroplasti
unit
state
project
exceed
million
year
complic
becom
common
differenti
pji
steril
inflamm
postop
period
remain
challeng
contemporari
diagnost
techniqu
commonli
use
imag
modal
laboratori
test
bacteri
cultur
noninvas
imag
modal
attract
option
offer
potenti
diagnos
monitor
assess
treatment
longitudin
suffici
sensit
resolut
achiev
xray
magnet
reson
imag
mri
reveal
gross
morpholog
chang
unfortun
produc
implantrel
artifact
especi
involv
metal
implant
obscur
relev
chang
surround
tissu
positron
emiss
tomographi
pet
gener
threedimension
tracer
concentr
imag
potenti
excel
sensit
without
implant
artifact
suffer
comput
tomographi
ct
mri
sensit
modal
abil
detect
infecti
burden
molecular
chang
occur
prior
macroscop
anatom
alter
wide
use
convent
tracer
includ
f
fdg
f
naf
ga
citrat
investig
pet
local
evalu
pji
variabl
success
howev
current
imag
approach
assess
indirect
marker
infectionmethod
often
hinder
low
specif
andor
sensitivityrath
directli
target
infecti
agent
altern
approach
improv
diagnosi
pji
may
use
target
probe
antibodi
peptid
radiolabel
antibodi
immunopet
long
use
investig
clinic
studi
oncolog
applic
prior
infectionrel
investig
focus
antibodi
human
target
white
blood
cell
indirect
marker
infect
studi
assess
antibodi
directli
target
gramposit
bacteria
staphylococcu
aureu
staphylococcu
epidermidi
bacteria
commonli
respons
pji
antibodi
direct
lipoteicho
acid
lta
surfaceassoci
compon
cell
wall
gramposit
bacteria
express
bacteria
high
level
antigen
promis
target
direct
imag
therapeut
agent
directli
target
infecti
agent
demonstr
improv
diagnost
capabl
noninvas
imag
may
guid
improv
patient
manag
vivo
model
aureu
pji
previou
work
bioluminesc
strain
demonstr
bioluminesc
signal
close
approxim
correl
bacteri
burden
measur
ex
vivo
colonyform
unit
cfu
count
vivo
bioluminesc
imag
bli
mice
demonstr
averag
signal
aureusinfect
postop
leg
pscm
sr
n
greater
mice
surgeri
perform
without
bacteri
inocul
pscm
sr
n
p
fig
b
infect
remain
local
origin
site
inocul
bioluminesc
signal
detect
background
region
bodi
addit
model
pji
result
expans
damag
distal
femur
infect
progress
confirm
ct
highresolut
xray
imag
fig
anatom
chang
distal
femur
aureusinfect
postop
leg
seen
clearli
compar
contralater
nonop
leg
f
fdg
imag
f
fdg
glucos
analog
taken
cell
high
glucos
avid
includ
tumor
inflamm
bacteria
volum
interest
defin
manual
around
area
focal
f
fdg
uptak
distal
femur
postop
contralater
nonop
leg
mice
salin
inject
aureu
infect
control
variabl
mous
size
data
present
averag
fold
increas
postop
leg
measur
contralater
nonop
leg
aureusinfect
postop
leg
larg
mean
increas
n
compar
doubl
n
steril
postop
leg
fig
see
signific
uptak
aureusinfect
surgic
postop
leg
compar
contralater
nonop
leg
p
suggest
probe
specif
local
infect
surgic
site
howev
glucos
avid
metabol
activ
cell
immun
cell
site
inflamm
follow
steril
implant
surgeri
complic
diagnosi
infect
fig
vivo
bioluminesc
imag
mous
model
pji
titanium
kirschnerwir
surgic
place
mous
femur
without
inoculum
bioluminesc
aureu
strain
knee
joint
prior
closur
repres
vivo
bioluminesc
signal
aureusinfect
postop
site
b
maximum
radianc
valu
individu
mean
sem
steril
control
implant
aureusinfect
postop
distal
femur
site
repres
time
point
vs
respect
c
ct
top
xray
bottom
imag
demonstr
locat
kirschnerwir
falsecolor
pink
ct
imag
distal
femur
p
bone
scan
f
naf
f
naf
incorpor
within
bone
matrix
site
increas
bone
turnov
natur
growth
physi
well
site
reactiv
bone
chang
occur
respons
infect
f
naf
uptak
evalu
pji
model
greater
f
naf
uptak
observ
aureusinfect
postop
leg
fold
n
steril
postop
leg
fold
n
p
fig
b
note
fold
increas
observ
steril
postop
leg
compar
contralater
nonop
leg
like
due
modest
bone
turnov
natur
occur
inflammatori
respons
implant
alon
ct
imag
femor
volum
defin
ct
scan
data
control
variabl
size
femur
individu
mice
data
present
averag
fold
increas
measur
postop
femur
contralater
nonop
femur
femur
volum
aureusinfect
postop
leg
doubl
bone
volum
entir
femur
n
compar
steril
postop
leg
slight
increas
nonop
counterpart
n
p
larg
size
structur
differ
seen
repres
scan
fig
taken
togeth
ct
data
analysi
show
aureusinfect
oper
leg
mark
expans
femur
volum
compar
steril
postop
leg
consist
previou
observ
specif
antilta
monoclon
antibodi
mab
order
specif
measur
infecti
entiti
develop
immunopet
agent
lta
cellsurfac
compon
gramposit
bacteria
antilta
mab
identifi
memori
b
cell
isol
patient
recov
aureu
skin
infect
human
immunoglobulin
evalu
bind
specif
select
ltaposit
strain
pathogen
bacteria
clinic
signific
affin
measur
octet
bind
immobil
lta
show
strong
bind
target
fig
also
found
wholecel
enzymelink
immunosorb
assay
elisa
bind
specif
ltaposit
bacteria
includ
aureu
epidermidi
gramneg
bacteria
specif
escherichia
coli
pseudomona
aeruginosa
wherea
control
igg
bind
ltaneg
bacteri
speci
test
fig
also
bound
vitro
grown
aureu
epidermidi
measur
flow
cytometri
presenc
human
sera
fig
thu
indic
bind
epitop
antilta
mab
obscur
presenc
human
sera
similarli
antilta
mab
retain
bind
bacteria
ex
vivo
indic
lta
express
epitop
access
antibodi
bind
bacteria
harvest
infect
mice
fig
result
indic
valid
candid
specif
detect
ltaexpress
bacteria
infect
anim
radiolabel
immunopet
imag
antilta
isotyp
control
igg
coval
conjug
deferoxamin
dfo
via
isothiocyanateamin
reaction
coval
linkag
subsequ
radiolabel
postpurif
radiotlc
confirm
puriti
show
radiopur
label
construct
fig
immunopet
imag
infect
implant
mice
zr
control
zr
igg
well
control
steril
implant
mice
conduct
h
day
post
inject
anim
receiv
antilta
antibodi
greater
signal
uptak
ratio
infect
implant
mice
receiv
control
igg
steril
implant
mice
receiv
antilta
antibodi
fig
surpris
find
pharmacokinet
full
igg
may
circul
day
week
antibodi
typic
accumul
day
background
signal
reduc
shown
repres
anim
fig
earli
time
point
enabl
clear
distinct
infect
site
use
specif
antibodi
nonspecif
control
steril
infect
model
p
day
specif
contrast
decreas
day
experi
nonspecif
uptak
skeleton
increas
correl
analysi
uptak
ratio
zr
label
antibodi
f
fdg
f
naf
perform
addit
suvmean
valu
zr
label
antibodi
bli
leg
undergon
surgic
implant
pin
signific
correl
differ
pet
imag
tracer
r
valu
twotail
pvalu
respect
weak
statist
signific
correl
standard
uptak
valu
suvmean
bioluminesc
signal
yield
r
valu
p
correl
result
indic
specif
antibodytarget
approach
bacteri
luminesc
lack
direct
associ
radiopur
radiopur
immunopet
conjug
determin
radioinst
thin
layer
chromatographyaft
purif
activ
conjug
retain
origin
evid
free
zirconium
migrat
plate
indic
inject
materi
contain
free
radiolabel
probe
work
requir
data
indic
bacterialspecif
tracer
zr
may
consider
valu
evalu
preclin
model
could
assist
detect
pji
clinic
set
diagnosi
pji
set
background
inflamm
complex
commonli
use
xray
ct
mri
may
reliabl
distinguish
steril
joint
loosen
infect
develop
bacteriaspecif
imag
probe
would
allow
differenti
infecti
process
steril
inflamm
sensit
pet
imag
would
particularli
valuabl
set
low
bacteri
burden
evalu
human
mab
direct
lta
compon
cell
wall
gramposit
bacteria
implic
pji
highaffin
mab
exhibit
specif
bind
gramposit
aureu
epidermidi
vitro
growth
fig
c
also
vivo
passag
mice
fig
intent
specif
noninvas
imag
bacteri
pathogen
directli
facilit
improv
sensit
detect
develop
zr
immunopet
agent
provid
statist
signific
distinct
presenc
infect
steril
implant
site
well
target
nonspecif
antibodi
typic
immunopet
imag
conduct
sever
day
administr
background
blood
pool
clearanc
antibodi
requir
distinguish
site
interest
consequ
util
rel
longliv
isotop
howev
observ
signal
ratio
zr
antilta
mab
aureusinfect
postop
leg
vs
contralater
nonop
leg
greatest
day
administr
specul
may
part
due
improv
immun
system
recognit
bacteria
antibodi
bind
lead
clearanc
bacteria
tracer
site
shorten
time
inject
imag
would
improv
logist
util
technolog
patient
may
allow
use
shorterliv
isotop
result
reduc
radiat
exposur
compar
convent
pet
tracer
ct
imag
f
fdg
previous
explor
nonspecif
probe
evalu
pji
vari
success
pet
provid
insight
metabol
host
tissu
cell
util
radioglucos
trap
tracer
local
pet
provid
millimeterscal
tomograph
imag
tracer
distribut
throughout
whole
bodi
ct
provid
higherresolut
attenu
map
use
anatom
local
abnorm
tissu
find
identifi
site
bone
degener
shown
fdg
uptak
surgic
distal
femur
infect
mice
much
greater
contralater
nonsurg
femur
also
correl
bli
find
surgic
vs
nonsurg
site
howev
also
found
increas
fdg
uptak
steril
surgic
leg
fig
suggest
uptak
due
inflamm
caus
surgeri
f
fdg
may
easili
identifi
robust
pji
indol
infect
low
bacteri
burden
activ
treat
may
indistinguish
steril
background
inflamm
f
naf
previous
use
assess
impact
tuberculosi
total
hip
arthroplasti
taken
surround
bone
matrix
degen
site
gross
morpholog
chang
seen
studi
month
infect
mous
model
chang
may
distinguish
absenc
longterm
infect
remodel
bone
due
steril
inflamm
may
preclud
distinct
indol
infect
vs
steril
inflamm
confirm
compar
steril
implant
contralater
knee
fig
ct
f
naf
pet
may
aid
earli
diagnosi
pji
may
use
substanti
remodel
occur
correl
analysi
across
pet
imag
probe
bacterialspecif
bioluminesc
indic
specif
antibodytarget
pet
imag
approach
studi
limit
part
fact
physe
mice
continu
activ
fuse
occur
human
result
sustain
bone
turnov
signal
end
long
bone
f
fdg
f
naf
howev
confound
control
compar
postop
joint
contralater
nonop
site
also
activ
physi
also
practic
consider
relev
compar
differ
imag
tracer
modal
translat
import
find
greater
accept
cancerimag
realm
zr
label
antibodi
pet
imag
still
perform
small
number
site
worldwid
ct
imag
f
fdg
f
naf
pet
routin
perform
provid
day
outpati
logist
often
mab
long
clearanc
time
inject
requir
sever
day
administr
imag
intriguingli
observ
optim
zr
imag
time
point
h
inject
bli
bacteria
small
anim
gener
feasibl
requir
genet
manipul
infecti
organ
may
alter
properti
model
suitabl
larger
anim
model
human
use
lightproduc
protein
highli
immunogen
provid
signal
suffici
superfici
imag
conclus
demonstr
abil
antilta
mab
immunopet
imag
probe
discrimin
infect
nonspecif
inflamm
preclin
mous
model
pji
highlight
potenti
shortcom
convent
pet
tracer
imag
model
plan
examin
role
molecularli
specif
imag
monitor
efficaci
mab
target
therapeut
clear
ltaposit
infect
investig
larger
anim
model
patient
need
determin
whether
zr
probe
translat
diagnos
pji
infect
clinic
practic
monoclonon
antibodi
mab
specif
lta
antilta
identifi
igg
memori
b
cell
select
patient
convalesc
aureu
skin
infect
erysipela
previous
describ
human
mab
direct
unrel
antigen
use
isotyp
control
human
antibodi
label
heterobifunct
chelat
pscnbndfo
macrocycl
dalla
tx
reagent
chemic
sigmaaldrich
st
loui
mo
unless
otherwis
state
mallinckrodt
institut
radiolog
washington
univers
medic
school
st
loui
mo
conjug
chelat
dfo
antibodi
antibodi
mol
l
hepe
ph
dfo
dimtethyl
sulfoxid
l
ad
three
time
follow
mix
final
dfo
antibodi
ratio
reaction
mix
room
tempteratur
min
excess
unreact
dfo
remov
centrifug
use
amicon
ultra
ml
centrifug
filter
ultracel
k
regener
cellulos
nmwl
emd
millipor
billerica
label
zr
excess
oxal
acid
ad
slowli
na
co
ad
bring
ph
zr
ad
dfoconjug
antibodi
reaction
mix
room
temperatur
min
chelat
free
zr
mmol
l
edta
ph
use
remov
centrifug
use
steril
salin
amicon
ultra
ml
centrifug
filter
ultracel
k
regener
cellulos
nmwl
emd
millipor
billerica
instant
thin
layer
chromatographi
itlc
perform
use
silica
impregn
filter
paper
pall
corpor
port
washington
ny
itlc
run
mmol
l
edta
ph
subsequ
imag
quantifi
use
phosphorimag
autoqu
softwar
packag
respect
packard
perkinelm
hopkinton
specif
control
antibodi
specif
activ
rang
mci
g
bacteria
inoculum
prepar
communityacquir
methicillinresist
staphylococcu
aureu
camrsa
strain
camrsa
kindli
provid
binh
diep
ucsf
san
francisco
ca
staphylococcu
epidermidi
strain
p
aeruginosa
strain
escherichia
coli
strain
obtain
american
type
cultur
collect
atcc
manassa
va
aureu
epidermidi
streak
isol
trypticas
soy
agar
tsa
plate
vwr
intern
radnor
pa
singl
coloni
inocul
tryptic
soy
broth
tsb
grown
overnight
p
aeruginosa
grown
overnight
tsa
plate
resuspend
tsb
appropri
optic
densiti
od
nm
bioluminesc
camrsa
strain
deriv
parent
strain
previous
describ
possess
bioluminesc
lux
construct
bacteri
chromosom
live
activ
metabol
bacteria
produc
light
light
product
maintain
progeni
without
select
midlogarithm
phase
bacteria
obtain
overnight
cultur
tsb
shake
r
min
follow
h
subcultur
dilut
desir
inoculum
bacteria
wash
reconstitut
steril
phosphatebuff
salin
pb
wholecel
elisa
bind
bacteria
overnight
cultur
wash
icecold
pb
vwr
intern
adjust
od
icecold
pb
elisa
plate
nunc
maxisorp
nalg
nunc
intern
rochest
ny
coat
bacteria
incub
overnight
plate
aureu
block
ml
rabbit
igg
sigmaaldrich
st
loui
mo
plate
bacteri
speci
block
bovin
serum
albumin
bsa
sigmaaldrich
st
loui
mo
pb
h
wash
volvol
pb
pbst
serial
dilut
isotyp
control
appli
plate
incub
h
plate
wash
time
pbst
bound
antibodi
detect
ml
horseradish
peroxidaseconjug
goatantihuman
igg
jackson
immunoresearch
laboratori
west
grove
pa
substrat
kpl
seracar
milford
reaction
stop
min
mol
l
h
od
measur
spectrophotomet
molecular
devic
sunnyval
ca
flow
cytometryin
vitro
grown
bacteria
flow
cytometri
vitro
grown
bacteria
conduct
overnight
bacteri
cultur
wash
icecold
pb
adjust
od
block
human
sera
h
one
wash
pb
bsa
pellet
incub
alexa
fluor
thermofish
scientif
waltham
label
ml
pb
presenc
human
sera
follow
two
wash
mab
bind
quantifi
flow
cytometri
lsrii
flow
cytomet
bectondickinson
franklin
lake
nj
flow
cytometryin
vivo
grown
bacteria
sixtoeightweekold
femal
mice
harlan
indianapoli
infect
intraperiton
inject
cfu
aureu
epidermidi
four
hour
postinfect
anim
euthan
blood
obtain
cardiac
punctur
pool
mice
icecold
sodium
citrat
weight
vol
final
concentr
eukaryot
cell
lyse
thermo
fisher
scientif
waltham
bacteria
recov
centrifug
min
r
min
bacteri
pellet
sonic
ml
icecold
pb
wash
pb
transfer
ubottom
plate
thermo
fisher
scientif
first
nonspecif
bind
protein
block
rabbit
antiprotein
immun
sera
min
bacteria
incub
antilta
mab
ml
h
wash
pb
incub
alexa
fluor
thermo
fisher
scientif
conjug
goat
antihuman
igg
min
jackson
immunoresearch
laboratori
west
grove
pa
follow
one
wash
live
bacteria
stain
min
room
temperatur
bodipi
fl
vancomycin
mab
bind
quantifi
octet
affin
measur
antilta
mabbind
kinet
purifi
lta
analyz
use
octet
instrument
slant
well
plate
fortebio
menlo
park
ca
aminopropylsilan
biosensor
first
load
ml
purifi
aureu
lta
sigmaaldrich
antilta
mab
nmol
l
associ
measur
follow
dissoci
kinet
buffer
fortebio
step
perform
use
sensor
offset
hz
sensit
data
export
prism
graphpad
la
jolla
ca
global
associationdissoci
affin
curv
fit
mous
model
pji
anim
procedur
approv
john
hopkin
univers
anim
care
use
committe
sixweekold
male
mice
jackson
laboratori
bar
harbor
use
experi
mous
model
pji
perform
previous
describ
briefli
medial
parapatellar
approach
use
access
right
distal
femur
disloc
patella
needl
use
ream
distal
femor
medullari
canal
thereaft
medicalgrad
kirschnerwir
mm
diamet
mm
length
modern
grind
port
washington
wi
insert
retrograd
fashion
approxim
mm
protrud
knee
joint
ad
steril
salin
steril
control
directli
inocul
cfu
patella
reloc
knee
surgic
close
use
two
interrupt
absorb
sutur
vivo
bli
postsurg
infect
confirm
direct
bli
bacteria
use
ivi
lumina
iii
imag
system
perkinelm
hopkinton
imag
larg
bin
min
exposur
perform
immedi
anesthet
mice
isofluran
surgeri
postop
day
signal
quantifi
use
live
imag
softwar
within
region
interest
roi
cm
center
surgic
knee
measur
maximum
radianc
photonssecondcm
steradian
limit
detect
photonsscm
sr
infect
establish
right
hind
limb
clear
hair
bioluminesc
imag
acquir
ivi
spectrum
perkin
elmer
ellipt
roi
cm
use
measur
persist
infect
inject
assay
use
sodium
iodid
dose
calibr
calibr
factor
capintec
ramsey
nj
mice
anesthet
isofluran
inhal
inject
intraven
via
retroorbit
sinu
averag
activ
tracer
dilut
final
volum
isoton
salin
f
fdg
petct
perform
follow
h
uptak
period
continu
isofluran
anesthesia
f
naf
mice
scan
follow
min
uptak
period
without
anesthesia
radiolabel
antibodi
prepar
detail
inject
assay
use
well
counter
calibr
factor
determin
previous
volum
radiolabel
antibodi
approxim
administ
intraven
via
retroorbit
sinu
mice
serial
scan
min
acquisit
kev
energi
window
day
micropet
system
concord
microsystem
inc
knoxvil
tn
follow
faxitron
digit
xray
imag
system
faxitron
bioptic
llc
tucson
az
petct
imag
sequenti
pet
min
acquisit
kev
energi
window
ct
scan
perform
use
superargu
smallanim
integr
petct
scanner
sedec
system
buffalo
grove
il
ct
paramet
acquisit
kvp
mm
aluminum
filtrat
imag
analysi
platform
amira
version
fei
hillsboro
use
merg
pet
ct
data
set
visual
f
fdg
uptak
relat
surgic
site
pet
highresolut
xray
imag
dedic
micropet
system
use
acquir
pet
scan
radiolabel
antibodi
listmod
data
acquir
use
gammaray
energi
window
kev
coincid
time
window
ns
pet
imag
data
correct
detector
nonuniform
dead
time
random
coincid
physic
decay
static
imag
scan
time
min
data
sort
histogram
fourier
rebin
transvers
imag
reconstruct
use
maximum
priori
algorithm
mm
mm
mm
matrix
data
set
analyz
use
asipro
vm
micropet
analysi
softwar
volum
interest
manual
defin
around
distal
femur
inject
activ
per
gram
calcul
empir
determin
system
calibr
factor
mice
use
convert
voxel
count
rate
activ
concentr
per
ml
tissu
figur
gener
use
amira
version
fei
hillsboro
directli
pet
scan
posit
planar
xray
imag
mice
acquir
use
faxitron
digit
xray
imag
system
faxitron
bioptic
llc
tucson
az
statist
analysi
data
statist
express
mean
sem
data
analyz
use
unpair
onetail
bli
f
fdg
f
naf
uptak
twotail
ct
volum
student
ttest
welch
correct
holmsidak
method
alpha
row
analyz
individu
without
assum
consist
standard
deviat
analysi
varianc
follow
bonferroni
multipl
comparison
test
use
assess
zr
antibodi
uptak
outlier
remov
via
analysi
absolut
varianc
rel
mean
pearson
correl
analysi
perform
prism
graphpad
version
pet
imag
zr
antibodi
use
ratio
uptak
surgic
vs
contralater
leg
fold
increas
uptak
f
fdg
f
naf
standard
uptak
valu
suvmean
zr
antibodi
surgic
pin
leg
vs
bioluminesc
flux
valu
limb
pvalu
consid
signific
